Vedolizumab for perianal Crohn’s disease: a multicentre cohort study in 151 patients

Chapuis-Biron C, Bourrier A, Nachury M, Nancey S, Bouhnik Y, Serrero M, Armengol-Debeir L, Buisson A, Tran-Minh ML, Zallot C, Fumery M, Bouguen G, Abitbol V, Viennot S, Chanteloup E, Rajca S, Dib N, Parmentier AL, Peyrin-Biroulet L, Vuitton L

(Aliment Pharmacol Ther. 2020 Apr;51(7):719-727 – PMID: 32080886)

https://pubmed.ncbi.nlm.nih.gov/32080886/